$1.33 Billion is the total value of BROADWOOD CAPITAL INC's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STAA | STAAR SURGICAL CO | $609,431,000 | -11.2% | 8,592,007 | 0.0% | 45.94% | -7.2% | |
MNST | MONSTER BEVERAGE CORP NEW | $431,656,000 | +16.0% | 4,656,488 | 0.0% | 32.54% | +21.3% | |
IWM | ISHARES TRrussell 2000 etf | $116,858,000 | -17.5% | 690,000 | 0.0% | 8.81% | -13.7% | |
AXON | AXON ENTERPRISE INC | $70,815,000 | -32.4% | 760,062 | 0.0% | 5.34% | -29.3% | |
LCTX | LINEAGE CELL THERAPEUTICS IN | $55,198,000 | +2.6% | 34,935,485 | 0.0% | 4.16% | +7.3% | |
OCX | Buy | ONCOCYTE CORP | $21,011,000 | -18.7% | 23,353,697 | +34.6% | 1.58% | -15.0% |
BTRS | New | BTRS HOLDINGS INC | $19,809,000 | – | 3,977,701 | +100.0% | 1.49% | – |
AGE | AGEX THERAPEUTICS INC | $1,727,000 | -32.5% | 2,997,156 | 0.0% | 0.13% | -29.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
ISHARES TR | 33 | Q3 2023 | 14.8% |
ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
BIOTIME INC | 25 | Q2 2019 | 17.8% |
AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-15 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
4 | 2024-01-10 |
4 | 2024-01-05 |
4 | 2023-11-30 |
13F-HR | 2023-11-14 |
4 | 2023-11-14 |
4 | 2023-11-09 |
4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.